How should you be preparing your wealth for a post-COVID-19 world?
Can COVID-19 be good for business?
Can COVID-19 be good for business while a Market volatility is continuing an ongoing global pandemic.2020??
Market volatility is continuing and it is difficult to pinpoint when this is likely to end!!
Markets are up one day and crashing down the next!!
With the usual conservative plays of gold and government bonds joining the rest of the market on this rollercoaster, some investors are now looking in some interesting places to shelter their money.
Melbourne-based biotech firm TBG Diagnostics Ltd [ASX:TDL] (formerly Progen Pharmaceuticals Ltd)
Melbourne-based biotech firm formerly Progen Pharmaceuticals Ltd
Progen Pharmaceuticals Limited and Avexa Limited Agree to Merge
- Creates one of Australia’s leading biotechnology companies
- Balanced portfolio of infectious disease and oncology assets with a Phase III HIV program
- Progen shareholders to have the option to participate in AUD $20M buyback
- Combined entity will have over AUD $60M cash
BRISBANE, Australia & MELBOURNE, Australia--(BUSINESS WIRE)--Biotechnology companies Progen Pharmaceuticals Limited (ASX:PGL) (NASDAQ:PGLA) and Avexa Limited (ASX:AVX) have signed an exclusive and binding Merger Implementation Agreement (MIA).
Progen will propose to shareholders an AUD$20 million share buyback option, to be completed prior to the merger.
The combined entity will have over AUD$60 million cash at transaction closing (assuming the AUD$20 million Progen share buyback is fully subscribed).
Shareholders from both companies will vote on the proposed merger in the first quarter of 2009.
Progen will propose to shareholders an AUD$20 million share buyback option, to be completed prior to the merger.
The combined entity will have over AUD$60 million cash at transaction closing (assuming the AUD$20 million Progen share buyback is fully subscribed).
Shareholders from both companies will vote on the proposed merger in the first quarter of 2009.
About Progen Progen Pharmaceuticals Limited is a globally focused biotechnology company committed to the discovery, development and commercialisation of small molecule pharmaceuticals primarily for the treatment of cancer.
Progen has built a focus and strength in anti-cancer drug discovery and development.
Progen targets the multiple mechanisms of cancer across its three technology platforms, angiogenesis, epigenetics and cell proliferation.
Progen has operations in Australia and the United States of America.
Two Investments Set to RISE as Coronavirus Rocks Global Markets
The coronavirus is a genuine concern for global markets.
Even with the number of cases steadily rising, markets looked remarkably bullish at the start of 2020.
Will this be a short-lived stock market panic followed by a quick recovery,or is it the start of something much Worse??
Markets are typically always motivated by one of two primal urges — fear or greed. Right now, fear is clearly dominating.
But this doesn’t mean you should seize up in fright…before dumping all your shares.
It would mean you need to think clearly about the companies and types of assets that could be beneficial in both the immediate future…and from whatever comes down the track.
‘Solution Stocks’. Ever heard of a company called Zoono Group Ltd [ASX:ZNO]?
What does it do? It produces a number of market-leading, germ-killing products like hand and surface sanitisers.
The problem here is that Zoono shares have burst out of the blocks already.
But there’s another ASX-listed company in the same field, which is yet to run, according to Lachlann.
This firm is seeking an all-important contract to bring its personal coronavirus testing kit to market.
It’s just one example of a handful of stocks that could follow in Zoono’s footsteps by providing workable solutions to the outbreak…
The problem here is that Zoono shares have burst out of the blocks already.
But there’s another ASX-listed company in the same field, which is yet to run, according to Lachlann.
This firm is seeking an all-important contract to bring its personal coronavirus testing kit to market.
It’s just one example of a handful of stocks that could follow in Zoono’s footsteps by providing workable solutions to the outbreak…
This is the future of antimicrobial technology.
BUSINESS PROTECTION PACKS
For Hands
For Surfaces
Long-lasting
Zoono lasts for up to 24 hours on skin & up to 30 days on surfaces.
Recommended by MicrobiologistsZoono’s effectiveness has been verified by over 100 lab results.
HOW ZOONO WORKS
1. Zoono bonds to the surface to create a protective layer
2. The Zoono surface attracts pathogens
3. The pathogen bursts like a balloon on contact
4. And you're protected!
AS FEATURED IN;
- One application of Zoono Hand Sanitiser in the morning provides an antibacterial protective layer all day so you can relax, knowing yo are protected!!
- Keep surfaces hygienic for longer without the hassle of sterilising every day! Using Zoono after you clean gives you germ-free surfaces for up to 30 days!!
- Distributor queries:info@zoono.com
- Wholesale queries: wholesale@zoono.com
Zoono Group Ltd [ASX:ZNO] is actually New Zealand based (but close enough) and not actually a biotech. The company deals in the development, manufacture, and global distribution of antimicrobial solutions.
Zoono’s Z71 Microbe Shield Surface Sanitiser was successfully tested in 2014 against bovine coronavirus.
What Is Bovine coronavirus?
Bovine coronavirus is a coronavirus which is a member of the species Betacoronavirus 1. The infecting virus is an enveloped, positive-sense, single-stranded RNA virus which enters its host cell by binding to the N-acetyl-9-O-acetylneuraminic acid recepter. Wikipedia
Calculating Your Future Returns: The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested.
No comments:
Post a Comment